Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A “Real-World” Open-Label Study on 1585 Patients
Nutrients · 17.01.2025 · 17 (2) · 328
DOI: 10.3390/nu17020328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 17.01.2025. Verfasst von Chiara Ricci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, ASST Spedali Civili di Brescia, University of Brescia, Piazza del Mercato 15, 25121 Brescia, Italy. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Acyclic Monoterpenes, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bologna, Diadema Farmaceutici, Italy..
Abstract (Originalsprache)
Objective
The objective of this study was to evaluate the efficacy of a very-low-absorbable geraniol formulation, administered as a food supplement, in patients with irritable bowel syndrome (IBS) in a real-world setting in Italy.
Methods
This open-label study was conducted in Italy on patients diagnosed with IBS and treated for 4 weeks with 240 mg/day of Palmarosa essential oil, absorbed on 960 mg of ginger root powder to obtain a very-low-absorbable geraniol formulation. Baseline characteristics, including demographic and symptoms were recorded using the IBS Severity Scoring System (IBS-SSS). After 28 ± 7 days, the patients were asked to complete the IBS-SSS questionnaire again. The primary objective was to confirm the effects of a very-low-absorbable geraniol formulation on self-reported symptoms of IBS and the quality of life of affected individuals. The secondary objective was to confirm the effect of the treatment on the different IBS subtypes.
Results
A total of 1585 patients were included in the study, with a mean age of 44.8 years and 56.4% women. Following the 4-week supplementation period, significant decreases were observed in the patients’ IBS-SSS (−67.9%) and all the primary IBS symptoms, such as abdominal distention (−82.3%), unsatisfaction with bowel habits (−46.2%), and interference with quality of life (QoL) (−64.9%) (all p < 0.01). The patients’ stool type improved significantly. Treatment was effective in all IBS subtypes.
Conclusions
Treatment with very-low-adsorbable geraniol food supplement was associated with improvements in symptoms and bowel habits in all IBS subtypes in a real-world setting in Italy. These findings support the use of geraniol as an effective option for patients with IBS regardless of the disease subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Unit, ASST Spedali Civili di Brescia, University of Brescia, Piazza del Mercato 15, 25121 Brescia, Italy.
- Microbiology Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Department of Biological, Geological and Environmental Sciences, University of Bologna, Via Selmi 3, 40126 Bologna, Italy.
ORCID-Profile: Chiara Ricci, Ilaria Maria Saracino, Renato Spigarelli, Irene Bellocchio, Enzo Spisni
Förderung
- University of Bologna, Diadema Farmaceutici, Italy.
Zitieren
APA
Ricci, C., Saracino, I. M., Valerii, M. C., Spigarelli, R., Bellocchio, I., & Spisni, E. (2025). Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A “Real-World” Open-Label Study on 1585 Patients. Nutrients, 17(2), 328. https://doi.org/10.3390/nu17020328
Vancouver
Ricci C, Saracino IM, Valerii MC, Spigarelli R, Bellocchio I, Spisni E. Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A “Real-World” Open-Label Study on 1585 Patients. Nutrients. 2025;17(2):328. doi:10.3390/nu17020328
BibTeX
@article{Ricci2025,
author = {Ricci, Chiara and Saracino, Ilaria Maria and Valerii, Maria Chiara and Spigarelli, Renato and Bellocchio, Irene and Spisni, Enzo},
title = {Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A “Real-World” Open-Label Study on 1585 Patients},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {2},
pages = {328},
doi = {10.3390/nu17020328}
}
EUVIMED